Search Results 7761-7770 of 26240 for oral
... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...
A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) ...
However, severe diarrhea (greater than 10 bowel movements a day or diarrhea where fluid losses are significantly greater than oral intake) can cause ...
- Unable to swallow oral tablets (crushing of study treatment tablets is not allowed). - Co-morbid systemic illnesses or other severe concurrent disease ...
Women who are sexually active with a male partner must agree to use at least one of the following birth control methods: hormonal therapy such as oral ...
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized ...
In addition, various exploratory markers of effectiveness will be analyzed. A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in ...
Conservative treatments for LFJA include oral analgesics and physical therapy. When conservative treatments are not beneficial, corticosteroid injections ...
control include hormonal contraceptives (oral, depot, injectable, transdermal, or intravaginal) or intrauterine device (IUD) for at least one week prior to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.